ストックスクリーナーアプリを入手
10.22
0.59%
0.06
アフターアワーズ：
10.22
前日終値:
$10.16
開ける：
$10.16
24時間の取引高:
16.64M
Relative Volume:
1.46
時価総額：
$45.62B
収益：
$14.35B
当期純損益:
$1.85B
株価収益率:
25.40
EPS:
0.4023
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+6.13%
1か月 パフォーマンス:
-0.87%
6か月 パフォーマンス:
+1.39%
1年 パフォーマンス:
+26.02%
1日の値動き範囲:
$10.16
$10.31
1週間の範囲:
$9.8211
$10.31
52週間の値動き範囲:
$8.06
$10.80
Haleon Plc Adr Stock (HLN) Company Profile
HLN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Haleon Plc Adr Stock (HLN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-05 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-01-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-08-06 | 開始されました | Berenberg | Buy |
| 2024-08-06 | ダウングレード | Goldman | Buy → Neutral |
| 2024-06-05 | 開始されました | Berenberg | Buy |
| 2024-04-17 | 開始されました | HSBC Securities | Buy |
| 2023-12-11 | 再開されました | Jefferies | Buy |
| 2023-11-01 | 開始されました | Morgan Stanley | Overweight |
| 2023-05-24 | 開始されました | Stifel | Hold |
| 2023-04-06 | アップグレード | Argus | Hold → Buy |
| 2023-04-04 | 開始されました | Bernstein | Outperform |
| 2022-12-07 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-09-28 | 開始されました | Argus | Hold |
すべてを表示
Haleon Plc Adr (HLN) 最新ニュース
Haleon PLC Executes Share Buyback to Optimize Capital Structure - TipRanks
Haleon takes full control of China JV with $0.2 billion deal - Investing.com
Haleon finalizes full ownership of Chinese JV for $0.2 billion - Investing.com
Haleon Announces PDMR Share Transactions in Compliance with UK Regulations - TipRanks
Haleon PLC Executes Share Buyback Program - TipRanks
Haleon receives A3 rating upgrade from Moody’s with stable outlook By Investing.com - Investing.com India
Haleon receives A3 rating upgrade from Moody's with stable outlook - Investing.com
Haleon PLC Executes Share Buyback to Enhance Shareholder Value - TipRanks
Haleon sets date for virtual 2025 Annual General Meeting By Investing.com - Investing.com South Africa
Haleon PLC Executes Share Buyback to Strengthen Market Position - TipRanks
Haleon PLC Announces Virtual 2025 Annual General Meeting - TipRanks
Haleon schedules virtual AGM for late May - Investing.com
Haleon sets date for virtual 2025 Annual General Meeting - Investing.com
Haleon updates share count and voting rights - Investing.com
Haleon plc launches £330 million share buyback By Investing.com - Investing.com South Africa
Haleon plc launches £330 million share buyback - Investing.com India
Haleon executives receive conditional share awards - Investing.com India
Haleon plc releases 2024 annual report and Form 20-F - Investing.com India
Pfizer to Exit Sensodyne-Maker Haleon With Final Stake Sale - MSN
GSK Stock Recovers, Rises Around 17% YTD: Time To Buy, Sell Or Hold? - Barchart
Pfizer Sells Remaining 7.3% Stake In Haleon For Around 3.3B - Barchart
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B - Yahoo Finance
Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion - Benzinga
Haleon completes share buyback with Pfizer exit - Investing.com
Haleon completes share buyback with Pfizer exit By Investing.com - Investing.com South Africa
Haleon plc to buy back shares from Pfizer in £170 million deal By Investing.com - Investing.com South Africa
Pfizer plans to sell final stake in Sensodyne producer HaleonBloomberg - Investing.com India
Haleon plc to buy back shares from Pfizer in £170 million deal - Investing.com India
Haleon to buy back shares from Pfizer in off-market deal By Investing.com - Investing.com South Africa
Haleon to buy back shares from Pfizer in off-market deal - Investing.com India
Pfizer offers for sale entire residual shareholding in Haleon - TipRanks
Haleon reports executive share acquisitions - Investing.com India
Haleon reports executive share acquisitions By Investing.com - Investing.com UK
HSBC cuts Haleon stock rating, maintains GBP4.20 target - Investing.com
Haleon Faces Headwinds From Weak Flu Season but Reaps Benefits From New Innovations - Morningstar
Why Haleon PLC Sponsored ADR Shares Are Under Scrutiny - TipRanks
Haleon PLC Reports Strong 2024 Financial Performance - TipRanks
Haleon PLC Reports 2024 Full-Year Results with Strong Organic Growth - TipRanks
HALEON ADR earnings beat, revenue fell short of estimates By Investing.com - Investing.com UK
Haleon PLC Reports Strong 2024 Financial Results and Strategic Progress - TipRanks
Haleon PLC Announces Shareholder Structure Change with Pfizer’s Conversion - TipRanks
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Haleon announces board change as Pfizer reduces stake - Investing.com
Haleon executives acquire shares under reward plan - Investing.com
Former Haleon Exec Appointed MD Of Kenvue’s Northern Europe Business - KamCity
Haleon plc ADR (HLN) Stock: A Year of Market Fluctuations - The InvestChronicle
Have you been able to find a good deal on Haleon plc ADR’s shares? - US Post News
Comstock Inc Inc. (LODE) Price Performance: A Technical Analysis Perspective - The InvestChronicle
QuantumScape Corp (QS) Shares Decline Despite Market Challenges - The News Heater
Haleon Plc Adr (HLN) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.16%
大文字化:
|
ボリューム (24 時間):